Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada 2026 Inflammatory Bowel Disease (IBD) Fellowship- United StatesRelease Date:Fellowship Inflammation & Immunology USA Title Grant Type Focus Area Country Application Due Date Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)Release Date:Partner: American College of Emergency Physicians (ACEP)Quality Improvement Internal Medicine USA HER2 Expression in Urothelial Carcinoma (UC)Release Date:Education Oncology All Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health OutcomesRelease Date:Quality Improvement Hospital Benin, Congo, The Democratic Republic Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid ArthritisRelease Date:Education Inflammation & Immunology USA Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate VaccinationRelease Date:Education Vaccines USA Community Oncology Support for Therapy Management in Multiple Myeloma (MM)Release Date:Education Oncology USA Management of Adults and Adolescents with Alopecia AreataRelease Date:Education Inflammation & Immunology USA Sickle Cell Disease Transition in CareRelease Date:Partner: National Alliance of Sickle Cell CentersQuality Improvement Rare Disease USA 2025 Rheumatology Fellowship – United StatesRelease Date:Fellowship Inflammation & Immunology USA Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)Release Date:Education Inflammation & Immunology USA Invasive Mold Diseases (IMD) & Treatment OutcomesRelease Date:Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom Implementing Updated RSV Immunization Recommendations for Older AdultsRelease Date:Education Vaccines USA